Stifel Maintains Buy on Astrana Health, Lowers Price Target to $45

Benzinga · 05/08 13:12
Stifel analyst Craig Jones maintains Astrana Health (NASDAQ:ASTH) with a Buy and lowers the price target from $50 to $45.